Copyright
©The Author(s) 2025.
World J Gastroenterol. Nov 28, 2025; 31(44): 111731
Published online Nov 28, 2025. doi: 10.3748/wjg.v31.i44.111731
Published online Nov 28, 2025. doi: 10.3748/wjg.v31.i44.111731
Table 1 Baseline characteristics of patients in the follow-up groups, mean ± SD
| Patient characteristics | Traditional (n = 74) | Internet plus (n = 71) | P value |
| Gender (male/female) | 58/52 | 45/38 | 0.645 |
| Age (years) | 58.4 ± 10.6 | 57.8 ± 10.2 | 0.485 |
| BMI (kg/m²) | 28.5 ± 3.4 | 28.3 ± 3.6 | 0.712 |
| Waist circumference (cm) | 95.3 ± 10.1 | 94.7 ± 10.5 | 0.623 |
| Glucose (mmol/L) | 6.3 ± 1.2 | 6.2 ± 1.3 | 0.524 |
| Cholesterol (mmol/L) | 5.4 ± 1.1 | 5.3 ± 1.2 | 0.487 |
Table 2 Follow-up adherence
| Traditional (n = 74) | Internet plus (n = 71) | P value | |
| Follow-up adherence rate (%) | 67.3 | 85.5 | < 0.01 |
Table 3 Comparison of alanine aminotransferase in non-alcoholic fatty liver disease patients during follow-up, mean ± SD
| Traditional (n = 74) | Internet plus (n = 71) | P value | |
| Before the follow-up | 45.2 ± 10.4 | 44.8 ± 10.2 | 0.564 |
| Following the follow-up | 50.3 ± 12.1 | 47.2 ± 11.3 | 0.004 |
| P value | 0.001 | 0.001 |
Table 4 Comparison of aspartate aminotransferase in non-alcoholic fatty liver disease patients during follow-up, mean ± SD
| Traditional (n = 74) | Internet plus (n = 71) | P value | |
| Before the follow-up | 40.3 ± 9.6 | 40.1 ± 9.5 | 0.879 |
| Following the follow-up | 45.1 ± 11.2 | 42.6 ± 10.4 | 0.009 |
| P value | 0.001 | 0.001 |
Table 5 Comparison of glucose in non-alcoholic fatty liver disease patients during follow-up, mean ± SD
| Traditional (n = 74) | Internet plus (n = 71) | P value | |
| Before the follow-up | 6.3 ± 1.2 | 6.2 ± 1.3 | 0.602 |
| Following the follow-up | 6.5 ± 1.3 | 6.3 ± 1.2 | 0.136 |
| P value | 0.099 | 0.621 |
Table 6 Comparison of cholesterol in non-alcoholic fatty liver disease patients during follow-up, mean ± SD
| Traditional (n = 74) | Internet plus (n = 71) | P value | |
| Before the follow-up | 5.4 ± 1.1 | 5.3 ± 1.2 | 0.821 |
| Following the follow-up | 5.6 ± 1.2 | 5.4 ± 1.1 | 0.002 |
| P value | 0.001 | 0.770 |
Table 7 Comparison of triglyceride in non-alcoholic fatty liver disease patients during follow-up, mean ± SD
| Traditional (n = 74) | Internet plus (n = 71) | P value | |
| Before the follow-up | 1.8 ± 0.6 | 1.7 ± 0.5 | 0.522 |
| Following the follow-up | 1.9 ± 0.7 | 1.8 ± 0.6 | 0.088 |
| P value | 0.090 | 0.094 |
Table 8 Comparison of physical function in non-alcoholic fatty liver disease patients during follow-up, mean ± SD
| Traditional (n = 74) | Internet plus (n = 71) | P value | |
| Before the follow-up | 70.2 ± 10.1 | 71.0 ± 9.8 | 0.220 |
| Following the follow-up | 71.5 ± 11.0 | 75.2 ± 10.3 | 0.001 |
| P value | 0.213 | 0.001 |
Table 9 Comparison of social function in non-alcoholic fatty liver disease patients during follow-up, mean ± SD
| Traditional (n = 74) | Internet plus (n = 71) | P value | |
| Before the follow-up | 72.1 ± 9.5 | 68.8 ± 10.0 | 0.215 |
| Following the follow-up | 73.3 ± 10.2 | 72.6 ± 9.8 | 0.001 |
| P value | 0.147 | 0.001 |
Table 10 Comparison of mental health in non-alcoholic fatty liver disease patients during follow-up, mean ± SD
| Traditional (n = 74) | Internet plus (n = 71) | P value | |
| Before the follow-up | 72.5 ± 8.4 | 73.0 ± 8.6 | 0.904 |
| Following the follow-up | 74.1 ± 9.1 | 78.9 ± 7.6 | 0.001 |
| P value | 0.157 | 0.001 |
- Citation: Liu SY, Gao GF, Wang XY, Yu J. Influence of an internet-based proactive follow-up management model on the prognosis of nonalcoholic fatty liver disease. World J Gastroenterol 2025; 31(44): 111731
- URL: https://www.wjgnet.com/1007-9327/full/v31/i44/111731.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i44.111731
